...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
Reply New Message
Back To Forum List View
Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
narmac
Jan 29, 2019 07:42PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
4
Nextblockbuster
Jan 30, 2019 07:36AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
tada
Jan 30, 2019 10:04AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
5
Nextblockbuster
Jan 30, 2019 10:14AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
5
KayakerBC
Jan 30, 2019 12:14PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
5
imtesty
Feb 01, 2019 08:55PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
6
tada
Feb 03, 2019 04:01AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
2
narmac
Feb 03, 2019 07:35AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
Toinv
Feb 08, 2019 03:26PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
Toinv
Feb 09, 2019 02:45PM
Icon president Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
1
BearDownAZ
Feb 10, 2019 10:07PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
2
Toinv
Feb 11, 2019 01:27PM

Toinv - One reason for the tepid approach by Pfizer is the Zenith is not tied to them with or after this TNBC deal where Triphase is tied to Celgene in their deal.

tada 

2 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply